BOCA RATON, Fla., Nov. 4, 2004 (PRIMEZONE) -- Pure H20 Bio-Technologies, Inc. (Pink Sheets:PHBT) announced today its commitment to combat waterborne diseases. At least 12% of United States households treat their drinking water in some fashion and industry analysts expect this number to increase to 40% by the year 2010. In an earlier market assessment, health officials estimate that 900,000 people each year become infected with waterborne disease and the General Accounting Office estimates that 66% of Safe Drinking Water Act violations are not reported. These findings along with the evolution of chlorine-resistant organisms suggest that the demand for high purity water by end users will continue to increase.
The PHBT point-of-entry water treatment systems provide another layer of protection for individual homes, businesses and healthcare facilities in the event that municipal systems become compromised with chlorine-resistant etiological agents. Researchers have long recognized the disinfection capability of iodine for over 170 years (Environmental Health Techniques in Rural Areas, Technische Universitat Hambur-Harburg, Germany, 1985 and W. Gottardi, University of Innsbruck, 1999). Historically, the concern has been to deliver the iodine in a manner that does not present a residual in treated potable water supplies. The PHBT technology provides a new water treatment option based on a system designed with both pre-and post-absolute carbon filtration used in combination with direct crystal iodine contact for disinfection. Moreover, the PHBT system is designed not to release detectable residual halogen into the disinfected water supplies. Both the iodine concentration and the contact time can be controlled independently of pH, and have demonstrated laboratory effective kill rates to a level of log 8 against microbial agents, as recent PHBT's test results confirm. Reminder: The CDC makes no recommendation as to the use of the portable filters on the market due to lack of independently verified results of their efficacy.
In addition, the World Health Organization has recommended the consideration of iodine for the control of cytomegalovarius (CMV) retinitis which is the most common cause of vision loss in HIV-positive patients, and that in the absence of effective antiviral medications, this form of retinitis is uniformly blinding, i.e., "Povidone-iodine, an inexpensive and broadly acting anti-infective agent with both antibacterial and antiviral properties, may hold great promise for the future particularly in developing countries." (Bulletin of the World Health Organization, 79(3), 2001.)
The Company:
PHBT is a publicly held company specializing in the manufacturing, design and sale of its unique residential, commercial and hospital point-of-use potable water disinfection systems. These systems are specifically designed to work effectively against water-borne pathogens and remove heavy metals and objectionable biomass.
Note: The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," "potential," "suggests," "may," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed of implied by such statements. In particular, management's expectations regarding future research, development, and/or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and completion in general. Forward-looking statements speak only as to the date they were made. The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
For further information regarding PHBT, please visit our website @ www.pureh2obiotech.com